![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PTRHD1 |
Gene summary for PTRHD1 |
![]() |
Gene information | Species | Human | Gene symbol | PTRHD1 | Gene ID | 391356 |
Gene name | peptidyl-tRNA hydrolase domain containing 1 | |
Gene Alias | C2orf79 | |
Cytomap | 2p23.3 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q6GMV3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
391356 | PTRHD1 | C57 | Human | Oral cavity | OSCC | 1.55e-06 | 6.34e-01 | 0.1679 |
391356 | PTRHD1 | C06 | Human | Oral cavity | OSCC | 1.14e-07 | 1.39e+00 | 0.2699 |
391356 | PTRHD1 | C07 | Human | Oral cavity | OSCC | 2.04e-04 | 1.75e+00 | 0.2491 |
391356 | PTRHD1 | C08 | Human | Oral cavity | OSCC | 3.09e-107 | 1.99e+00 | 0.1919 |
391356 | PTRHD1 | C09 | Human | Oral cavity | OSCC | 1.61e-02 | 3.73e-01 | 0.1431 |
391356 | PTRHD1 | LN22 | Human | Oral cavity | OSCC | 3.57e-11 | 1.60e+00 | 0.1733 |
391356 | PTRHD1 | LN38 | Human | Oral cavity | OSCC | 4.47e-07 | 1.57e+00 | 0.168 |
391356 | PTRHD1 | LN46 | Human | Oral cavity | OSCC | 5.94e-05 | 6.77e-01 | 0.1666 |
391356 | PTRHD1 | LP15 | Human | Oral cavity | LP | 5.57e-17 | 2.65e+00 | 0.2174 |
391356 | PTRHD1 | LP17 | Human | Oral cavity | LP | 6.90e-10 | 1.60e+00 | 0.2349 |
391356 | PTRHD1 | SYSMH1 | Human | Oral cavity | OSCC | 4.61e-14 | 3.81e-01 | 0.1127 |
391356 | PTRHD1 | SYSMH2 | Human | Oral cavity | OSCC | 5.61e-35 | 1.12e+00 | 0.2326 |
391356 | PTRHD1 | SYSMH3 | Human | Oral cavity | OSCC | 5.49e-39 | 1.18e+00 | 0.2442 |
391356 | PTRHD1 | SYSMH4 | Human | Oral cavity | OSCC | 1.68e-10 | 2.73e-01 | 0.1226 |
391356 | PTRHD1 | SYSMH5 | Human | Oral cavity | OSCC | 2.03e-07 | 3.35e-01 | 0.0647 |
391356 | PTRHD1 | SYSMH6 | Human | Oral cavity | OSCC | 1.45e-17 | 5.47e-01 | 0.1275 |
391356 | PTRHD1 | P5_S10_cSCC | Human | Skin | cSCC | 3.99e-03 | -1.34e-01 | -0.299 |
391356 | PTRHD1 | P1_cSCC | Human | Skin | cSCC | 3.43e-42 | 1.43e+00 | 0.0292 |
391356 | PTRHD1 | P2_cSCC | Human | Skin | cSCC | 6.06e-21 | 8.00e-01 | -0.024 |
391356 | PTRHD1 | P4_cSCC | Human | Skin | cSCC | 4.09e-32 | 8.64e-01 | -0.00290000000000005 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PTRHD1 | SNV | Missense_Mutation | c.109N>A | p.Gln37Lys | p.Q37K | Q6GMV3 | protein_coding | tolerated(1) | benign(0.007) | TCGA-AR-A1AR-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | Docetaxel | PD | |
PTRHD1 | SNV | Missense_Mutation | novel | c.99G>T | p.Lys33Asn | p.K33N | Q6GMV3 | protein_coding | tolerated(0.2) | benign(0.346) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
PTRHD1 | SNV | Missense_Mutation | c.122C>T | p.Ser41Phe | p.S41F | Q6GMV3 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-AY-4070-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | 5-fu | PD | |
PTRHD1 | SNV | Missense_Mutation | c.278N>C | p.Glu93Ala | p.E93A | Q6GMV3 | protein_coding | tolerated(0.64) | benign(0.001) | TCGA-CI-6624-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PTRHD1 | SNV | Missense_Mutation | c.347N>T | p.Ala116Val | p.A116V | Q6GMV3 | protein_coding | deleterious(0) | benign(0.112) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
PTRHD1 | SNV | Missense_Mutation | c.314A>C | p.His105Pro | p.H105P | Q6GMV3 | protein_coding | deleterious(0) | probably_damaging(0.955) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
PTRHD1 | SNV | Missense_Mutation | novel | c.226N>T | p.Gly76Trp | p.G76W | Q6GMV3 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-49-6761-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PTRHD1 | SNV | Missense_Mutation | c.29N>C | p.Arg10Pro | p.R10P | Q6GMV3 | protein_coding | tolerated_low_confidence(0.18) | benign(0) | TCGA-49-AAR3-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
PTRHD1 | SNV | Missense_Mutation | c.313N>G | p.His105Asp | p.H105D | Q6GMV3 | protein_coding | deleterious(0) | probably_damaging(0.955) | TCGA-91-6848-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | CR | |
PTRHD1 | SNV | Missense_Mutation | novel | c.381N>C | p.Glu127Asp | p.E127D | Q6GMV3 | protein_coding | tolerated(0.56) | possibly_damaging(0.751) | TCGA-KK-A8IG-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |